Dana-Farber Cancer Institute implements Informatica Platform

NewsGuard 100/100 Score

News Facts:

  • Today Informatica Corporation (Nasdaq:INFA), the world's number one independent provider of enterprise data integration software, announced that Dana-Farber Cancer Institute, one of the leading cancer care and research centers in the United States, has implemented the Informatica Platform enterprise wide.
* The Informatica solution: * Enhances day-to-day financial decision-making and strengthens Dana-Farber's cancer research capabilities. * Empowers a broad spectrum of Dana-Farber administrators with daily detailed operating expense data by integrating large volumes of data across multiple departmental systems. * Significantly improves budgeting process and helps ensure funds are spent in the most effective manner. * Accelerates the preparation of funding reports around Dana-Farber's $250 million annual research grants - reducing time required to produce these vital reports from six days to just one and a half days. * Helps Dana-Farber quickly: * Integrate large volumes of patient data from inside and outside the Institute, identify trends in patient care across in- and out-patient services; * Predict staffing and supply requirements; and, * Apply treatment resources to where they are most needed. * Provides researchers with a more timely and accurate view on balances remaining on specific grants, when to apply for new grants, or when to renew existing ones. * Enables Dana-Farber to handle multiple types of data, at nearly any latency, from virtually any type of business and clinical data source, including medical record transactions in Health Level 7 (HL7), relational databases, flat file extracts, mainframe data and XML. * Dana-Farber standardized on Informatica to gain a single, scalable data integration platform capable of addressing all present and future business and clinical intelligence needs. * New data integration projects will now benefit from built-in data profiling and data quality capabilities that accelerate the introduction of new data and data sources while helping to ensure the completeness, integrity and relevance of Dana-Farber's information. * Plans include a new business intelligence project in which the Informatica Platform will incorporate a variety of patient data from multiple sources to enable the analysis of patient care.

Quotes

  • "Informatica provides Dana-Farber Cancer Institute with a powerful data integration platform that can be expanded to address our future integration challenges," said Rob Sutfin, data warehouse program manager, Dana-Farber. "The graphical development toolset helps to streamline the development process, and we benefit from Informatica's support and experience as a professional data integration provider."
     
  • "The top-of-mind concerns of today's healthcare organizations – reducing healthcare costs, optimizing the use of resources and improving patient outcomes – all benefit from timely access to comprehensive, trusted data," said Shekhar Iyer, senior vice president, Healthcare and Public Sector, Informatica.  "The Informatica Platform is proven to help healthcare organizations address their unique data challenges, from enhancing data quality across huge and constant volumes of diverse data to automating vital processes and ensuring compliance to creating a single view of the patient throughout the cycle of care."
SOURCE Informatica Corporation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tumor microbiomes offer new insights for enhancing cancer therapies